These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Parathyroid function in acromegaly. Aloia J; Powell D; Mendizibal E; Roginsky M Horm Res; 1975; 6(3):145-9. PubMed ID: 1218855 [TBL] [Abstract][Full Text] [Related]
3. Familial acromegaly: a specific clinical entity--further evidence from the genetic study of a three-generation family. Benlian P; Giraud S; Lahlou N; Roger M; Blin C; Holler C; Lenoir G; Sallandre J; Calender A; Turpin G Eur J Endocrinol; 1995 Oct; 133(4):451-6. PubMed ID: 7581969 [TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P J Clin Endocrinol Metab; 1998 Aug; 83(8):2621-6. PubMed ID: 9709921 [TBL] [Abstract][Full Text] [Related]
5. Familial acromegaly. Jones MK; Evans PJ; Jones IR; Thomas JP Clin Endocrinol (Oxf); 1984 Mar; 20(3):355-8. PubMed ID: 6723082 [TBL] [Abstract][Full Text] [Related]
6. Hyperproinsulinaemia in acromegaly: evidence for abnormal pancreatic beta-cell function? Gama R; Teale JD; Wright J; Ferns G; Marks V Ann Clin Biochem; 1997 Nov; 34 ( Pt 6)():627-31. PubMed ID: 9366999 [TBL] [Abstract][Full Text] [Related]
7. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918 [TBL] [Abstract][Full Text] [Related]
9. A non-acromegalic case of multiple endocrine neoplasia type 1 accompanied by a growth hormone-releasing hormone-producing pancreatic tumor. Sugihara H; Shibasaki T; Tatsuguchi A; Okajima F; Wakita S; Nakajima Y; Tanimura K; Tamura H; Ishii S; Kamegai J; Akasu H; Kitagawa W; Shimizu K; Nakamura Y; Uchida E; Tajiri T; Naito Z; Katakami H; Oikawa S J Endocrinol Invest; 2007 May; 30(5):421-7. PubMed ID: 17598976 [TBL] [Abstract][Full Text] [Related]
10. Familial acromegaly - case study of two sisters with acromegaly. Malicka J; Świrska J; Nowakowski A Endokrynol Pol; 2011; 62(6):554-7. PubMed ID: 22144223 [TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. Gadelha MR; Prezant TR; Une KN; Glick RP; Moskal SF; Vaisman M; Melmed S; Kineman RD; Frohman LA J Clin Endocrinol Metab; 1999 Jan; 84(1):249-56. PubMed ID: 9920092 [TBL] [Abstract][Full Text] [Related]
12. The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours. Lamberts SW; Klijn JG; Kwa GH; Birkenhäger JC Acta Endocrinol (Copenh); 1979 Feb; 90(2):198-210. PubMed ID: 105530 [No Abstract] [Full Text] [Related]
13. Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease. Dreijerink KM; van Beek AP; Lentjes EG; Post JG; van der Luijt RB; Canninga-van Dijk MR; Lips CJ Eur J Endocrinol; 2005 Dec; 153(6):741-6. PubMed ID: 16322378 [TBL] [Abstract][Full Text] [Related]
14. [Parathyroid hormone and calcitonin in acromegaly]. Kasatkin IuN; Larina IM; Ametov AS Probl Endokrinol (Mosk); 1981; 27(4):21-4. PubMed ID: 7291147 [TBL] [Abstract][Full Text] [Related]
15. Acromegaly in a family without a mutation in the menin gene. Ackermann F; Krohn K; Windgassen M; Buchfelder M; Fahlbusch R; Paschke R Exp Clin Endocrinol Diabetes; 1999; 107(1):93-6. PubMed ID: 10077364 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly. Losa M; Schopohl J; König A; Müller OA; von Werder K J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095 [TBL] [Abstract][Full Text] [Related]
18. Endogenous hyperinsulinemia and release of growth hormone following a glucose load as well as in response to thyrotropin releasing hormone in acromegaly. Saad MJ; Moreira AC; Foss MC Braz J Med Biol Res; 1990; 23(10):953-7. PubMed ID: 2129261 [TBL] [Abstract][Full Text] [Related]
19. Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1. Parfitt VJ; Flanagan D; Wood P; Leatherdale BA Clin Endocrinol (Oxf); 1998 Nov; 49(5):647-52. PubMed ID: 10197081 [TBL] [Abstract][Full Text] [Related]
20. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]